Filing Details
- Accession Number:
- 0001179110-12-015131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-12 19:47:28
- Reporting Period:
- 2012-10-10
- Filing Date:
- 2012-10-12
- Accepted Time:
- 2012-10-12 19:47:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1344153 | H Jeffrey Knapp | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-10-10 | 14,100 | $24.50 | 28,139 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-10-10 | 14,100 | $26.00 | 14,039 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-10-10 | 914 | $25.00 | 13,125 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-10-10 | 14,100 | $0.00 | 14,100 | $24.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,900 | 2020-01-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The award vests on a monthly basis in equal installments during the 48 month period beginning on January 1, 2010.